Analyst Ratings for ORIC Pharmaceuticals (ORIC)
ORIC Rating Summary
ORIC Price Target Summary
- Highest: $25.00 (H.C. Wainwright)
- Lowest: $15.00 (Oppenheimer)
- Average: $20.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$20.50 (+49.5%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 89%
Avg. $ Target:
$20.50 (+49.5%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 89%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/7/2026 | Piper Sandler | Kelsey Goodwin | New Coverage | Overweight (N/A) |
22.00 (N/A) |
8.15 (13.71) |
68.22% | Details |
| 12/4/2025 | Goldman Sachs | Corinne Johnson | New Coverage | Early-Stage Biotech (N/A) |
N/A (N/A) |
10.98 (13.71) |
24.86% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
